Here are four things to know about the company’s stock:
1. Bacterin’s stock has a one-year low of $2.19 and a one-year high of $8.10.
2. The stock’s 50-day moving average is $4 and its 200-day moving average is $3.
3. The company’s market cap is $28.4 million.
4. In early April, Bacterin announced that its stock will be trading on the OTCQX marketplace after the New York Stock Exchange suspended trading the company’s common stock.
More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics’ 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
